Concepedia

Tom Hofland

TH

Statistics

Publications

8

Citations

506

H-Index

8

Active since

2014

Affiliations

Amsterdam University Medical Centers(Current)

University of Amsterdam

Albert Schweitzer Ziekenhuis

Cancer Center Amsterdam

Lymphoma Research Foundation

Tom Hofland is an author at Amsterdam University Medical Centers specializing in immunology, life sciences, and cancer immunology.

ORCID

Publications per year

2014–2020

8

Publications

8

Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy

Jaco A. C. van Bruggen, Anne W. J. Martens, Joseph A. Fraietta et al. · Blood · 2019 · 186 citations · Full text

, , +14

Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment

Iris de Weerdt, Tom Hofland, Renate de Boer et al. · Blood Advances · 2019 · 107 citations · Full text

, , +17

Recognition of LPS by TLR4: Potential for Anti-Inflammatory Therapies

Reindert Nijland, Tom Hofland, Jos A. G. van Strijp · Marine Drugs · 2014 · 73 citations · Full text

, , +17

Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib

Iris de Weerdt, Tom Hofland, Roeland Lameris et al. · Blood · 2018 · 50 citations · Full text

, , +12

Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor

Cameron L. Lilly, Nancy Villa, Ana Lemos de Matos et al. · Molecular Therapy — Oncolytics · 2016 · 34 citations · Full text

, , +15

1–5 of 8